Login

Financial Snapshot

Revenue
TTM
$181.6M
Gross Margin
TTM
32.2%
Net Income
TTM
$12.56M
Current Assets
2024 Q2
Current Liabilities
2024 Q2
Current Ratio
2024 Q2
680.06%
Total Assets
2024 Q2
Total Liabilities
2024 Q2
$21.48M
Book Value
2024 Q2
$238.9M
Cash
2024 Q2
P/E
TTM
64.46
Free Cash Flow
TTM
$27.68M

Stock Price

Loading...
Market Cap: $809.44 Million

About ATRION CORP

Atrion Corp. engages in the manufacture and development of products for medical applications. The company is headquartered in Allen, Texas and currently employs 712 full-time employees. The firm's medical products are used in a number of fields including fluid delivery, cardiovascular, and ophthalmic applications. The company has developed a variety of proprietary valves designed to precisely fill, hold, and release and/or remove controlled amounts of fluids, including blood and drugs, or gasses on demand for use in areas such as intubation, intravenous, catheter, and other applications in fields including anesthesia and oncology. The core of its cardiovascular products is its Myocardial Protection System, a technology that is the only open-heart surgery system that delivers to the heart essential fluids and medications, mixes critical drugs, and controls temperature, pressure, and other important variables. The firm also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.

Industry: Surgical & Medical Instruments & Apparatus Peers: Avanos Medical Inc Embecta Corp BioLife Solutions Inc CERUS CORP Figs Inc MERIDIAN BIOSCIENCE INC OrthoPediatrics Corp Silk Road Medical Inc UFP Technologies Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support